← Leaderboards
Myron Steve Ignatius
Massachusetts General Hospital
$1,107,720
Attributed
$1,107,720
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2014–19$250K$187.5K$125K$62.5K$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,107,720 · 2
By mechanism
R00$747,000 · 1
K99$360,720 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- David Michael Langenau$26,574,494
- Konrad Hochedlinger$15,714,725
- Gian Paolo Dotto$22,106,352
- David T Scadden$62,181,067
- E. Antonio Chiocca$34,514,665
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneIn VivoGenesImageInhibitor/AntagonistIn VitroGene ChipsCell TransplantationGrowthHuman DiseaseAnimalsCell FractionClinically RelevantCell LineCellsBaseDna BindingEmbryonal RhabdomyosarcomaCell DivisionGenetic EpistasisChildFishesChildhood Soft Tissue SarcomaIn Vivo Imaging
Grant awards (5)
A role for notch in self renewal in embryonal rhabdomyosarcoma$249,000
R00 · FY2019 · CA · contact PI
A role for notch in self renewal in embryonal rhabdomyosarcoma$249,000
R00 · FY2018 · CA · contact PI
A role for notch in self renewal in embryonal rhabdomyosarcoma$249,000
R00 · FY2017 · CA · contact PI
A role for notch in self renewal in embryonal rhabdomyosarcoma$180,360
K99 · FY2015 · CA · contact PI
A role for notch in self renewal in embryonal rhabdomyosarcoma$180,360
K99 · FY2014 · CA · contact PI